Rational Development of Liquid Biopsy Analysis in Renal Cell Carcinoma

Rational Development of Liquid Biopsy Analysis in Renal Cell Carcinoma

Renal cell carcinoma (RCC) is known for its variable clinical behavior and outcome, including heterogeneity in developing relapse or metastasis. Recent data highlighted the potential of somatic mutations as promising biomarkers for risk stratification in RCC. Likewise, the analysis of circulating tu...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kate I. Glennon, Mahafarin Maralani, Narges Abdian, Antoine Paccard, Laura Montermini, Alice Jisoo Nam, Madeleine Arseneault, Alfredo Staffa, Pouria Jandaghi, Brian Meehan, Fadi Brimo, Simon Tanguay, Janusz Rak, Yasser Riazalhosseini
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
renal cell carcinoma
liquid biopsy
NGS
cfDNA
ctDNA
extracellular vesicles
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Accès en ligne:https://doaj.org/article/e16a1ef71eb64074ade75295117b9a5a
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/e16a1ef71eb64074ade75295117b9a5a

Documents similaires